Tina Guilder joins Linden Capital Partners' Portfolio Company, Virtus Pharmaceuticals, as CEO |
Tina Guilder joins Linden Capital Partners' Portfolio Company, Virtus Pharmaceuticals, as CEOTampa, FL (September 25, 2015) – The Board of Directors of Virtus Pharmaceuticals LLC today announced that Tina Guilder has joined as Chief Executive Officer. Ms. Guilder served most recently as President and CEO of TWi Pharmaceuticals. Prior to TWi Pharmaceuticals, Ms. Guilder was Vice President of Business Development and Alliance Management for Teva Pharmaceuticals. Ms. Guilder has spent the last twenty years in the pharmaceutical and healthcare industries spanning corporate strategy, finance, and business development with a particular focus on generic and specialty products. Ms. Guilder has an undergraduate degree and a Master in Business Administration from the University of Southern California. |